← Martin B. Leon

Papers by Martin B. Leon

Page 8 · newest first

351. Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve ReplacementSHILAP Revista de lepidopterología · 2017
352. Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses: Insights from the PARTNER II Valve-in-Valve Registry on Utilizing Baseline Computed-Tomographic AssessmentStructural Heart · 2017
353. Biomarkers in Aortic Stenosis: A Systematic ReviewStructural Heart · 2017
354. Atrial Fibrillation is Associated with Increased Pacemaker Implantation Rates in the Placement of AoRTic Transcatheter Valve (PARTNER) TrialJournal of Atrial Fibrillation · 2017
355. Injuries to the Aorta, Aortic Annulus, and Left Ventricle During Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Interventions · 2016
356. Medical Treatment of Aortic StenosisCirculation · 2016
357. Outcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES)EuroIntervention · 2016
358. Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital DeathJAMA · 2016
359. Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trialEuroIntervention · 2016
360. Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves)Circulation Cardiovascular Interventions · 2016
361. Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three‐dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserveCatheterization and Cardiovascular Interventions · 2016
362. Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal DiseaseJournal of the American Heart Association · 2016
363. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatmentEuroIntervention · 2016
364. Treatment of Higher-Risk Patients With an Indication for RevascularizationCirculation · 2016
365. In vivo delivery and long-term tissue retention of nano-encapsulated sirolimus using a novel porous balloon angioplasty systemEuroIntervention · 2016
366. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic StenosisCirculation · 2016
367. Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial ProgramEuroIntervention · 2016
368. Transcatheter Interatrial Shunt Device for the Treatment of Heart FailureCirculation Heart Failure · 2016
369. Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic StenosisJAMA Cardiology · 2016
370. Transcatheter Replacement of Failed Bioprosthetic ValvesCirculation Cardiovascular Interventions · 2016
371. VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studiesEuroIntervention · 2016
372. Percutaneous paravalvular leak closure: chasing the chameleonEuropean Heart Journal · 2016
373. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three‐dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trialCatheterization and Cardiovascular Interventions · 2016
374. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsNew England Journal of Medicine · 2016
375. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosisEuropean Heart Journal · 2016
376. An update on the clinical use of drug-coated balloons in percutaneous coronary interventionsExpert Opinion on Drug Delivery · 2016
377. Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve ReplacementAnnals of Internal Medicine · 2016
378. Transcatheter Aortic Valve Replacement: 2015 in ReviewJournal of Interventional Cardiology · 2016
379. Diagnosis and Management of Aortic Valve Stenosis in Patients with Heart FailureEuropean Journal of Heart Failure · 2016
380. Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Interventions · 2016
381. Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for AtherothrombosisCirculation Cardiovascular Interventions · 2016
382. Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administrationEuropean Heart Journal · 2015
383. Risk stratification of patients undergoing medical therapy after coronary angiographyEuropean Heart Journal · 2015
384. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic ValvesNew England Journal of Medicine · 2015
385. Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Success and safetyCatheterization and Cardiovascular Interventions · 2015
386. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation IndexEuroIntervention · 2015
387. Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacementHeart · 2015
388. Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Technical performanceCatheterization and Cardiovascular Interventions · 2015
389. Chronic pacing and adverse outcomes after transcatheter aortic valve implantationHeart · 2015
390. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitionsEuropean Heart Journal · 2015
391. Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Quality and Outcomes · 2015
392. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysisHeart · 2015
393. Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It RightJournal of Clinical Hypertension · 2015
394. Comparison between two‐ and three‐dimensional quantitative coronary angiography bifurcation analyses for the assessment of bifurcation lesions: A subanalysis of the TRYTON pivotal IDE coronary bifurcation trialCatheterization and Cardiovascular Interventions · 2015
395. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?European Heart Journal · 2015
396. Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve ReplacementCirculation · 2015
397. Effect of Tricuspid Regurgitation and the Right Heart on Survival After Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Interventions · 2015
398. Treatment and Clinical Outcomes of Transcatheter Heart Valve ThrombosisCirculation Cardiovascular Interventions · 2015
399. Infective Endocarditis After Transcatheter Aortic Valve ImplantationCirculation · 2015
400. Echocardiographic Imaging of Procedural Complications During Balloon-Expandable Transcatheter Aortic Valve ReplacementJACC. Cardiovascular imaging · 2015